Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
Prostate and bladder cancer represent the two most frequently diagnosed genito-urinary malignancies. Diet has been implicated in both prostate and bladder cancer. Given their prolonged latency and high prevalence rates, both prostate and bladder cancer represent attractive candidates for dietary pre...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/48da058874894328adb5d041255c840d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:48da058874894328adb5d041255c840d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:48da058874894328adb5d041255c840d2021-11-25T18:33:44ZKaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature10.3390/nu131137502072-6643https://doaj.org/article/48da058874894328adb5d041255c840d2021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/3750https://doaj.org/toc/2072-6643Prostate and bladder cancer represent the two most frequently diagnosed genito-urinary malignancies. Diet has been implicated in both prostate and bladder cancer. Given their prolonged latency and high prevalence rates, both prostate and bladder cancer represent attractive candidates for dietary preventive measures, including the use of nutritional supplements. Flavonols, a class of flavonoids, are commonly found in fruit and vegetables and are known for their protective effect against diabetes and cardiovascular diseases. Furthermore, a higher dietary intake of flavonols was associated with a lower risk of both bladder and prostate cancer in epidemiological studies. In this systematic review, we gathered all available evidence supporting the anti-cancer potential of selected flavonols (kaempferol, fisetin and myricetin) against bladder and prostate cancer. A total of 21, 15 and 7 pre-clinical articles on bladder or prostate cancer reporting on kaempferol, fisetin and myricetin, respectively, were found, while more limited evidence was available from animal models and epidemiological studies or clinical trials. In conclusion, the available evidence supports the potential use of these flavonols in prostate and bladder cancer, with a low expected toxicity, thus providing the rationale for clinical trials that explore dosing, settings for clinical use as well as their use in combination with other pharmacological and non-pharmacological interventions.Felice CrocettoErika di ZazzoCarlo BuonerbaAchille AvetaSavio Domenico PandolfoBiagio BaroneFrancesco TramaVincenzo Francesco CaputoLuca ScafuriMatteo FerroVincenzo CosimatoFerdinando FuscoCiro ImbimboGiuseppe Di LorenzoMDPI AGarticlefisetinkaempferolmyricetinprostate cancerbladder cancerNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 3750, p 3750 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
fisetin kaempferol myricetin prostate cancer bladder cancer Nutrition. Foods and food supply TX341-641 |
spellingShingle |
fisetin kaempferol myricetin prostate cancer bladder cancer Nutrition. Foods and food supply TX341-641 Felice Crocetto Erika di Zazzo Carlo Buonerba Achille Aveta Savio Domenico Pandolfo Biagio Barone Francesco Trama Vincenzo Francesco Caputo Luca Scafuri Matteo Ferro Vincenzo Cosimato Ferdinando Fusco Ciro Imbimbo Giuseppe Di Lorenzo Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature |
description |
Prostate and bladder cancer represent the two most frequently diagnosed genito-urinary malignancies. Diet has been implicated in both prostate and bladder cancer. Given their prolonged latency and high prevalence rates, both prostate and bladder cancer represent attractive candidates for dietary preventive measures, including the use of nutritional supplements. Flavonols, a class of flavonoids, are commonly found in fruit and vegetables and are known for their protective effect against diabetes and cardiovascular diseases. Furthermore, a higher dietary intake of flavonols was associated with a lower risk of both bladder and prostate cancer in epidemiological studies. In this systematic review, we gathered all available evidence supporting the anti-cancer potential of selected flavonols (kaempferol, fisetin and myricetin) against bladder and prostate cancer. A total of 21, 15 and 7 pre-clinical articles on bladder or prostate cancer reporting on kaempferol, fisetin and myricetin, respectively, were found, while more limited evidence was available from animal models and epidemiological studies or clinical trials. In conclusion, the available evidence supports the potential use of these flavonols in prostate and bladder cancer, with a low expected toxicity, thus providing the rationale for clinical trials that explore dosing, settings for clinical use as well as their use in combination with other pharmacological and non-pharmacological interventions. |
format |
article |
author |
Felice Crocetto Erika di Zazzo Carlo Buonerba Achille Aveta Savio Domenico Pandolfo Biagio Barone Francesco Trama Vincenzo Francesco Caputo Luca Scafuri Matteo Ferro Vincenzo Cosimato Ferdinando Fusco Ciro Imbimbo Giuseppe Di Lorenzo |
author_facet |
Felice Crocetto Erika di Zazzo Carlo Buonerba Achille Aveta Savio Domenico Pandolfo Biagio Barone Francesco Trama Vincenzo Francesco Caputo Luca Scafuri Matteo Ferro Vincenzo Cosimato Ferdinando Fusco Ciro Imbimbo Giuseppe Di Lorenzo |
author_sort |
Felice Crocetto |
title |
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature |
title_short |
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature |
title_full |
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature |
title_fullStr |
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature |
title_full_unstemmed |
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature |
title_sort |
kaempferol, myricetin and fisetin in prostate and bladder cancer: a systematic review of the literature |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/48da058874894328adb5d041255c840d |
work_keys_str_mv |
AT felicecrocetto kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT erikadizazzo kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT carlobuonerba kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT achilleaveta kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT saviodomenicopandolfo kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT biagiobarone kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT francescotrama kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT vincenzofrancescocaputo kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT lucascafuri kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT matteoferro kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT vincenzocosimato kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT ferdinandofusco kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT ciroimbimbo kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature AT giuseppedilorenzo kaempferolmyricetinandfisetininprostateandbladdercancerasystematicreviewoftheliterature |
_version_ |
1718410949879136256 |